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INTRODUCTION
Alzheimer's Disease
Background Information
Alzheimer's disease (AD) is a neuropsychiatric condition that mainly affects the
elderly and with approximately 4.5 million cases in the United States alone, AD is the
most prevalent neurodegenerative disorder (Hebert, Scherr, Bienas, Bennet & Evans,
2003). AD is a progressive neurological disorder, and the neurodegeneration and
dementia seen in AD is unlike the natural decline in memory function associated with
normal aging (Lesne et al., 2006). Dementia is a brain disorder that seriously affects a
person's ability to carry out daily activities, and is defined as an acquired decline of
mental functions in relation to the patient's previous level of functioning (DSM-IV-TR,
2000). According to the DSM-IV-TR there are as many as 12 different classifications for
dementia, and it is a disorder characterized by the development of multiple cognitive
deficits (including memory impairment) which are not due to the direct physiological
effects of a general medical condition, to the persisting effects of a substance, or to
multiple etiologies (p. 147). Dementia of the Alzheimer's type is the most prevalent
form of age-dependent dementia affecting parts of the brain thought to control memory,
language, and thought (Small, Mok, & Bornstein, 2001).
At the present time the exact cause of AD is unknown, and there is no known cure
for this disease (National Institutes of Health [NIH], 2007). Dementia of the Alzheimer's
type increases dramatically with age, rising from about 0.6% in males and 0.8% in
females at age 65, to 11% in males and 14% in females at age 85, and eventually as high
as 36% in males and 41% in females at age 95 (DSM-IV-TR, 2000, p. 156). It should not

2
be surprising, then, that as the life-expectancy in developed countries continues to
increase, so to does the incidence of AD and its socioeconomic impact on society as a
whole (Mueller et al., 2005). Although a great deal of research has already been
conducted in this area, no definitive claims can yet be made regarding the cause of the
neurodegeneration associated with AD. If researchers can identify the cause(s) of the
some of the earliest symptoms of AD (e.g., memory impairment), then treatments could
be developed which directly target those variables in order to slow, stop or reverse the
process of neurodegeneration.
Diagnosis
According to the DSM-IV-TR a thorough clinical examination is necessary to
diagnose dementia of the Alzheimer's type. This diagnosis is made mainly on the basis
of symptoms, and several important criteria must be met. Memory impairment, which is
a prominent and early symptom of AD, is the first diagnostic criterion required to make a
diagnosis of dementia of the Alzheimer's type. Memory may be formally tested by
asking individuals to register, retain, recall and recognize information. The diagnostician
may simply ask the individual to repeat a list of words (registration), then ask the person
to recall the information after a delay of several minutes (retention and recall), and also to
recognize the word from a list of multiple words (recognition). Memory can also be
examined with non-human subjects via different means which do not involve language,
such as maze navigation assays (DSM-IV-TR, 2000, p. 157). One such non-human animal
assay of memory will be discussed in more detail in a later section.
In addition to the impairments in memory, individuals suffering from dementia of
the Alzheimer's type will also exhibit impairments in other cognitive functions. Mental
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impairments may extend to areas such as motor performance, language, judgment,
executive functions (i.e., planning, organizing, sequencing, abstracting), visuospatial
skills, emotional functions, and personality change. The diagnosis also requires that the
severity of symptoms be such that they significantly interfere with the individual's life.
The course of dementia of the Alzheimer's type is characterized by gradual onset and
continuing decline, and adherence to this course is required for the diagnostic criteria to
be met (DSM-IV-TR, 2000, p. 157).
Differentiating among the 12 types of dementia listed in the DSM-IV-TR is made
by discovering the etiology of the dementia. Researchers are attempting to develop tests
which are both sensitive and specific to confirm a diagnosis of dementia of the
Alzheimer's type. No such test currently exists and, therefore, it remains a diagnosis of
exclusion. In other words, a diagnosis of dementia of the Alzheimer's type requires that
the 11 other types of dementia must first be ruled out. Specifically, the cognitive deficits
must not be due to other central nervous system conditions that cause progressive deficits
in memory or cognition (e.g., cerebrovascular damage, Parkinson's or Huntington's
disease), systemic conditions that are known to cause dementia (e.g., HIV infection,
hypothyroidism, or vitamin Bn deficiency), or due to the effects of persistent use of a
substance (e.g., alcohol). A diagnosis of dementia of the Alzheimer's type also requires
that the deficits not occur exclusively during the course of delirium, and that the
cognitive disturbance is not better accounted for by another Axis I disorder such as
Schizophrenia (DSM-IV-TR, 2000, p. 157).
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Incidence, Prevalence and Course
Researchers estimate that in the year 2000 about 4.5 millions Americans were
living with AD, and in 50 years that number is expected to triple to 13 million (Hebert et
al., 2003). The percentage of total persons diagnosed with AD varies from state to state
depending on population factors such as age. For example, the percentage of persons
with AD in the year 2005 was projected to be as low as 0.9% of the total population of
Alaska, and as high as 2.9% of the total population of Florida (Hebert, Scherr, Bienias, &
Bennet, 2004). Age is a major risk factor for neurodegenerative diseases in general, and
particularly for AD. AD is known to be a prominent disorder of old age because the
disease typically begins to manifest after the age of 60 years and continues to increase
with age. In fact, about 5% of individuals between the ages of 65 and 74 years have AD,
whereas nearly 50% of individuals over the age of 85 years may have the disease.
Although younger individuals (i.e., those under the age of 60 years) may also develop
AD, it is much less common in this group (NIH, 2007).
The course and speed of progression of AD varies from person to person, but the
disease is neurodegenerative in that it generally begins with mild memory impairments
and continues to degenerate until the final stages in which severe brain damage is evident
(NIH, 2007). The period of time, before a diagnosis can be made, when those mild
memory impairments may be evident is known as the prodromal or preclinical period
(Small, Gangon, & Robinson, 2007). There are no qualitative differences between the
cognitive deficits preceding a diagnosis of AD and the loss of cognitive abilities that
accompanies normal aging, but there are quantitative differences. That is, the degree or
severity of prodromal cognitive deficits is greater in persons who go on to receive a
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diagnosis of AD than in those whom do not (Craft, Cholerton, & Reger, 2003). Once an
individual is diagnosed with AD they tend to live an average of 8-10 years, although
individuals may live with the disease for as many as 20 years after receiving a diagnosis.
Unfortunately, dementia of the Alzheimer's type is thought to be an irreversible
phenomenon. However, scientists continue to look for ways to delay or prevent the
neurodegenerative processes associated with AD (NIH, 2007).
Signs and Symptoms of Alzheimer's Disease
Cognitive Signs and Symptoms
The cognitive effects of AD involve disruptions to memory, language, thinking
and reasoning (Alzheimer's Association, 2007). Studies suggest that poor cognitive
performance, specifically poor memory function, is one of the earliest symptoms of AD
and can predict the disease up to 15 years prior to the onset of any clinical dementias
(Kawas et al., 2003). The two major forms of memory are classified by their duration
and include short-term memory and long-term memory. Short-term memory is rapidly
formed and can outlast training for minutes or hours, whereas long-term memory may
last from hours to days, weeks, or even years (James, 1890). It is important to note that
the earliest symptom of AD is the impairment of short-term working memory (Selkoe,
2002). Over time, both declarative and non-declarative memory will become impaired.
Episodic memory, a type of memory involved in remembering verbal or visual materials,
may also serve as a good marker for impending dementia (Good, Hale, & Staal, 2007). A
deficit in visual memory performance is another early expression of AD, and may also be
evident years before a diagnosis is made (Kawas et al., 2003).
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In its earliest phase AD produces a remarkably pure impairment of memory, in
the absence of any other signs of brain injury. As the disease progresses, however, a
variety of other cognitive impairments begin to emerge. Patients with AD begin to lose
their ability to encode new information (i.e., form new memories), at first being unable to
memorize the trivial, and then later the more important, details of life. Furthermore, one
of the first manifestations of this progressive disease, noted primarily in the early stages,
is a profound inability to form new memories (Selkoe, 2002). Although individuals have
difficulty learning new information, their motor and sensory functions remain otherwise
intact (Alzheimer's Association, 2007). In addition, the individual begins to lose their
capacity for reasoning, abstraction, and even language (Selkoe, 2002). Other cognitive
domains may also be affected, including executive functioning (i.e., organizational skills)
and the ability to respond rapidly to verbal and visual materials (e.g., driving a car,
following directions; Small et al., 2007). Furthermore, individuals with dementia of the
Alzheimer's type appear to exhibit an accelerated breakdown in certain inhibitory
processes (Spieler, Balota, & Faust, 1996).
Behavioral Signs and Symptoms
The "behavioral" or "psychiatric" symptoms describe a large group of additional
symptoms that occur (at least to some degree) in many, but not all, individuals with AD.
Personality changes in the form of irritability, anxiety and/or depression are common
disturbances which may first be demonstrated in the early stages of AD. Other symptoms
that may occur in the later stages of AD include sleep disturbances, agitated behaviors,
delusions, and/or hallucinations. Physical or verbal outbursts, general emotional distress,
restlessness, pacing, shredding paper, and yelling are all examples of agitated behaviors.
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An example of a delusion might be a firmly held belief that a person has a characteristic
not actually present (e.g., a great singing voice), while examples of hallucinations could
include seeing, hearing or feeling things that are not actually there. It is the behavioral
and psychiatric symptoms which are often the most distressing to individuals with AD,
their families, and their caregivers. Although other factors might contribute to the
occurrence of these symptoms (e.g., medication), the chief underlying cause of the
behavioral and psychiatric symptoms of AD is the progressive neurodegeneration
associated with the disease itself (Alzheimer's Association, 2007).
According to a report of the Surgeon General, psychosis, depression, and
wandering are also common behavioral symptoms of AD (U.S. Department of Health and
Human Services, 1999). Other behavioral symptoms discussed in the Surgeon General's
report include insomnia; incontinence; catastrophic verbal, emotional, or physical
outbursts; sexual disorders; and weight loss. Although these behavioral symptoms are
not required for a diagnosis of AD, they do have serious ramifications and potentially
detrimental consequences to the quality of life of AD sufferers and their caregivers. This
is a major concern because for most individuals the behavioral symptoms will occur at
some point during the disease with high frequencies. For example, 30 to 50% of
individuals with AD will experience delusions, 10 to 25% will have hallucinations, and
40 to 50% will suffer from symptoms of depression (U.S. Department of Health and
Human Services, 1999, Ch. 5, p. 4).
Physiological Signs and Symptoms
In 1906 a German doctor by the name of Dr. Alois Alzheimer noticed areas of
abnormal brain tissue while conducting an autopsy on a woman who had died of an
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unusual mental illness. Dr. Alzheimer had identified abnormal clumps of brain tissue as
well as tangled bundles of fibrous brain tissue, which are now known as amyloid plaques
and neurofibrillary tangles (NFTs), respectively (Figure 1). Today, these plaques and
tangles are a hallmark of AD and are considered to be a sign of the disease. Furthermore,
the progressive loss of short-term working memory is correlated with the accumulation of
large amyloid plaques and NFTs in the hippocampus and other areas of the brain
involved in memory processing (NTH, 2007).

Normal

Alzheimer's

Figure 1. Amyloid Plaques and Neurofibrillary Tangles (NFTs).
This diagram represents the two hallmarks of Alzheimer's disease: amyloid plaques and
NFTs. On the left is normal or healthy brain tissue, and on the right is the unhealthy
Alzheimer's brain tissue.
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Neurofibrillary Tangles. NFTs are twisted nerve cell fibers which are the
damaged remains of microtubules (Alzheimer's Association, 2005). Microtubules are the
support structures which allow the flow of nutrients through the neurons (nerve cells). A
key component of these tangled fibers is an abnormal form of the tau protein which, in its
healthy state, helps in the assembly of the microtubule structure. Defective tau, however,
appears to actually block the actions of the healthy tau protein. Essentially, when the
defective tau protein fails to support the microtubule structure it inhibits the supportive
actions of the healthy tau proteins, thereby preventing the flow of the nutrients through
the neurons. The damaged remains of the microtubules then begin to accumulate forming
NFTs (Simon, 2003). NFTs are the most commonly found intraneuronal inclusion in the
brains of patients with neurodegenerative diseases (SantaCruz et al., 2005).
Beta-Amyloid. The second significant feature discovered in the brains of AD
individuals is commonly referred to as either beta-amyloid (P-amyloid) or amyloid beta
(AP). Beta-amyloid is an insoluble protein that can accumulate forming sticky patches.
These patches may be called one of several names (i.e., oligomers, fibrils, beta sheets, or
plaques) depending on how much Ap has accumulated. Regardless, these sticky patches
of AP are often found surrounded by the debris of dying nerve cells in the brains of AD
victims (Simon, 2003). When nerve cells die and connections between nerve cells are
disrupted in areas of the brain that are crucial to memory and other mental abilities,
impairments in these abilities are assured (NIH, 2007). The p-amyloid peptide is a 38 to
43 amino-acids long sequence derived from the large transmembrane P-amyloid
precursor protein (APP). The most common forms are 40 and 42 amino acid residues
long and are termed Ap40 and Ap42, respectively (Glenner & Wong, 1984). It has been
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suggested that the accumulation of A|342 plays a causative role in the characteristic
neurodegeneration associated with AD (Sweeney, Luedtke, McDonald, & Overmier,
1997). The distinction between the different forms of AP (i.e., A04O vs. A042;
oligomers, fibrils, sheets and plaques) will be covered in greater detail in a later section.
In addition to nerve cell death, amyloid plaques are relevant to some other
identified brain characteristics associated with AD. For instance, higher levels of AP are
associated with reduced levels of the neurotransmitter acetylcholine. Neurotransmitters
are chemical messengers in the brain which carry messages between nerve cells.
Acetylcholine is part of the cholinergic system, which is a system involved in learning
and memory. Thus, AD may impair thinking and memory by disrupting these messages.
AP may also disrupt channels that carry sodium, potassium and calcium. These elements
act as ions in the brain, producing electric charges that must fire regularly in order for
signals to pass from one nerve cell to another (Simon, 2003). If the channels that carry
these ions are disrupted or damaged, such an imbalance could interfere with nerve
function and signal transmission (Alzheimer's Association, 2008).
AP is also relevant to a process called oxidation, which may be responsible for
some of the neurodegeneration associated with AD (Simon, 2003). When AP breaks
down it releases chemicals called oxygen-free radicals which, once released, bind to other
molecules in a process called oxidation. Although the oxidation process is a normal one,
when oxidants are over-produced they can cause severe damage in cells and body tissue.
When the body's immune factors attempt to repair the injuries caused by oxidation yet
another problem may arise as a result of the body's inflammatory response. The
inflammatory response occurs when the immune system responds to a threat but, in the
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process, actually damages the body's own cells (NIH, 2007). A full account of oxidation
and the inflammatory response is beyond the scope of the present analysis, but it is
important to point out that these processes do provide further evidence for the potential
importance of AP in the development of AD.
Models, Theories, and Hypotheses of Alzheimer's Disease
Before moving on to the various hypotheses regarding AP, it is first necessary to
understand the relationship between Ap and its precursor protein. Amyloid-P is derived
from the amyloid precursor protein (APP). To form Ap, APP is first cleaved by Psecretase, and then is subsequently cleaved by y-secretase (Figure 2). Depending on the
point of cleavage of y-secretase, any of three different principle forms of AP will be
produced. These three forms of Ap compromise 38,40, or 42 amino acids and, therefore,
the three forms are called Ap38, Ap40, and Ap42, respectively. AP40 is the most
abundant peptide, however, Ap42 is the longest form and is far more likely to
oligomerize and form amyloid fibrils (Alzheimer's Association, 2006).
The reason that Ap42 is a prime suspect in AD is because it is chemically
"stickier" than other fragments produced when APP is cut, which causes it to accumulate.
It accumulates by stages into microscopic amyloid plaques that are considered one of the
hallmarks of the Alzheimer brain. The pieces first form small clusters called oligomers,
then chains of clusters called fibrils, then "mats" of fibrils called beta sheets. The final
stage is plaques, which contain clumps of beta sheets and other substances (Alzheimer's
Association, 2006). The normal process of Ap production goes awry when there is either
an over-production of all Ap or an increased proportion of the 42 amino acid form, both
of which may cause early-onset AD (Walsh & Selkoe, 2007).
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The "Myelin Model"
Bartzokis, Lu and Mintz (2007) hypothesize that myelin breakdown in vulnerable
late-myelinating regions releases oligodendrocyte- and myelin-associated iron that
promotes Ap oligomerization, its associated toxicity, and the deposition of oligomerized
Ap and iron in neuritic plaques observed in AD. Multiple risk factors such as age, certain
genetic predisposition, and increasing Ap and iron levels, result in thinner myelin sheaths
which are differentially lost with age in a pattern of bilaterally progressive myelin
breakdown. This process is thought to underlie the progressive, bilaterally symmetrical
spread of the pathognomonic lesions of AD (i.e., neuritic plaques and NFTs). The myelin
model is of interest to this analysis because of its emphasis on Ap oligomers.
Genetic Models
The major known genetic risk factor for AD is the apolipoprotein E-4 (ApoE-e4),
an epsilon4 allele associated with lowered parietal, temporal, and posterior cingulate
cerebral glucose metabolism in patients with a clinical diagnosis of AD (Small et al.,
2000). However, the exact genetic markers for the disease differ depending on whether it
is early- or late-onset AD. In early-onset AD of the familial form, the disease appears to
be caused by mutations on chromosomes 21,14, and 1 and is transmitted in autosomal
dominant mode. Each of these mutations appears to result in an overproduction of the
protein found in neuritic plaques (i.e., P-amyloid). The early-onset familial form of the
disease accounts for less than 5% of AD cases, which is a relatively small proportion of
total cases (Cummings, Vinters, Cole, & Khachaturian, 1998). However, according to
Mohs, Breitner, Silverman and Davis (1985) if individuals with a family history of AD
are followed into their 80s and 90s approximately 50% will develop the disorder
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themselves (i.e., late-onset AD). The results of twin studies suggest that heredity is
involved in about 60% of all cases of AD, and this percentage includes both the earlyand late-onset varieties (Bergem, Engedal, & Kringlen, 1997).
Late-onset AD is the more common form of the disorder, and begins after 60
years of age. Genetic studies have identified an association between late-onset AD and
the presence of the ApoE-e4 allele on chromosome 19 (Bookheimer et al., 2000). In
addition to being the chief genetic risk factor for AD, ApoE-e4 is also the most common
cause of dementia late in life. Functional MRI scanning comparing subjects with this
genetic marker to normal subjects have indicated that patterns of activation differ
between these two groups (Bookheimer et al., 2000). Specifically, it appears that
individuals with this genetically predisposing allele show increased signal intensity (i.e.,
greater activation) in brain regions necessary for tasks requiring memory including the
left hippocampal, parietal and prefrontal regions. This increased brain activation is
hypothesized to be the result of compensatory processing, that is, greater brain activation
is required to meet the task demands when compared to healthy controls. In other words,
the individuals with the ApoE-e4 allele have to work harder to perform the same memory
tasks. Regardless, the presence of the ApoE-e4 allele on chromosome 19 has been shown
to increase the risk for developing AD because this allele increases the deposition of Pamyloid. Once again, the critical variable appears to be the over-production and
accumulation of 3-amyloid.
Amyloid Hypotheses
Amyloids are insoluble fibrous protein aggregations sharing specific structural
traits. The abnormal accumulation of amyloids in organs can lead to amyloidosis, which
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may play a role in certain diseases including AD. Ap is a small self-aggregating peptide
produced at low levels by normal brain metabolism. Researchers suggest that in AD,
self-aggregation of A(3 becomes rampant and is manifested as the amyloid fibrils of senile
plaques. These fibrils are known to kill neurons in culture, which suggests that the fibrils
might initiate the neurodegeneration associated with AD (Klein, Grant & Finch, 2001).
More recently, however, it has been determined that the Ap fibrils are not the only form
of Ap relevant to AD. Research suggests that the smaller, pre-fibrillar assemblies of Ap
oligomers are also deleterious (Walsh & Selkoe, 2007).
Although several hypotheses regarding the cause of AD are currently under
investigation, one which has garnered a great deal of evidence is the amyloid cascade
hypothesis (Hardy & Higgens, 1992). This hypothesis contends that AD is the result of
an accumulation of senile plaques consisting mainly of P-amyloid peptides. According to
this hypothesis, the memory loss seen in AD occurs due to neuron death caused by
fibrillar Ap. Research based on this hypothesis, however, has failed to demonstrate a
convincing correlation between dementia and amyloid plaque burden. To address this
issue a newer hypothesis has emerged which suggests that early memory loss is
considered a synapse failure caused by soluble Ap oligomers (Lacor et al., 2004). Such
oligomers are believed to block long-term potentiation, and they are strikingly elevated in
AD brain tissue and transgenic mouse AD models.
A hypothesis proposed by Matsuoka and colleagues (2003) compares the body's
immune system to a sink, which traps Ap and depletes it from the central nervous system.
Under this hypothesis, the neurodegeneration associated with AD (i.e., dead or dying
neurons, activated microglial cells, and reactive astrocytes) is thought to be the result of
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the interaction between the body's immune system and Ap aggregation. This hypothesis
rests on the assumption that Ap aggregation is the causal event in AD pathology, because
amyloid deposits of Ap found in the limbic and association cortices are surrounded by
signs of neurodegeneration (Mrak & Griffin, 2001).
Although the exact etiology of AD is still unknown, the ever-accumulating
knowledge about the histopathology of AD is allowing for the development of drugs
aimed at modifying the neurodegenerative process of this devastating disease (Mueller et
al., 2005). One leading hypothesis has proposed that these senile plaques, which are
formed by aberrant processing of APP, are an important step in synaptic, neuronal, and
cognitive deterioration (Hardy, 2006). Although the evidence for the role of Ap in AD is
both suggestive and encouraging, it is by no means exact or conclusive. What is known
is that the neuropathological features of AD include amyloid plaques, NFTs, and
selective neuronal loss. The impetus for these features and their exact causal role in the
symptomology of AD, however, requires a great deal more research.
Researchers have examined mice with APP mutations and have found that they
develop impairments in hippocampus-dependent memory tasks (Janus, Phinney, Chishti,
& Westaway, 2001). Such findings are consistent with the amyloid hypothesis.
Neurobiological theories contend that the hippocampus carries out functions relevant to
spatial information and episodic memory (Smith & Mizumori, 2006). Although an allencompassing account of the function of the hippocampus and the various types of
memory is beyond the scope of the present analysis, it is worth describing spatial and
episodic memory. In 2005 Geary and colleagues reported that naturally produced Ap
oligomers from 7PA2 cells, but not Ap monomers or non-Ap CM, produced cognitive
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impairments in rats tested under an alternating lever cyclic ratio (ALCR) procedure.
Holscher, Gengler, Gault, Harriot and Mallot (2007) reported reversible effects when
they found that three daily ICV injections of soluble A(3(25-35) produced short- and
long-term memory impairment in rats tested in a radial arm maze on post-injection days
12-20, but not on post-injection days 3-11 or 20-28. The difference in the time-course of
effects with soluble A(3 (25-35) and with 7PA2 is noteworthy and merits investigation
with respect to mechanism.
Experimental Memory Assays and Alzheimer's Disease
Experimental assays of memory are especially important to the study of AD since
a wide variety of memory disruptions have been implicated in this disease. Before
moving on to some of the experimental assays of memory used to study AD, it is
important to first understand a bit about the different classifications of memory as they
pertain to AD. Memory is divided into two main categories based on duration which
include short-term memory and long-term memory (James, 1890). Short-term memory is
further divided into sensory memory and working memory, and working memory is
further divided into visual memory and executive memory (Baddeley, 2003). The type of
memory used for the temporary maintenance and storage of information is commonly
referred to as short-term working memory, whereas long-term memory refers to a more
permanent storage of information and can be further divided into declarative memory and
procedural memory (James, 1890). Declarative memory refers to facts, events or
relationships and is further divided into semantic memory and episodic or spatial memory
(Tulving & Markowitsch, 1998). Unfortunately, memory is not discussed in a consistent
manner across research studies, which can make understanding the distinction between
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various memory assays difficult. Figure 3 is a visual representation of the subdivisions of
memory and all of the aforementioned types of memory relevant to animal models of AD
are highlighted in yellow (i.e., short-term, working, visual, executive, long-term,
declarative, and spatial). This figure should become useful as some of the experimental
animal models of AD are presented.
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X
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X

Episodic or
Spatial
Memory

Figure 3. Visual Representation of the Subdivisions of Memory
*The types of memory relevant to animal models of AD are highlighted in yellow.
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The ALCR Schedule
The ALCR schedule of food reinforcement is a very sensitive behavioral assay for
examining the effects of a variety of psychoactive drugs (O'Hare et al., 1996; Weldon,
O'Hare, Kuskowski, Cleary, & March, 1996) and insoluble forms of Ap (Richardson et
al., 2002) on the behavior of non-human subjects. The ALCR procedure is a type of
schedule-controlled behavior requiring subjects to move from one lever to the other each
time a specific response requirement is met and it enables the simultaneous measurement
of anticipatory ratio tracking (post-reinforcement pause durations), preservations (leverswitching errors), and non-specific peripheral drug effects (running response rates). This
modified version of the cyclic-ratio schedule was originally designed to examine the
effects of atropine sulfate on reference memory (Weldon et al., 1996).
In 2005 Cleary and colleagues used the ALCR assay to examine the memory of
rats and demonstrated disruptive effects to the memory of complex learned behavior
when a solution of 7PA2 CM containing Ap dimers and trimers (but not monomers) was
injected into the lateral ventricles. Although this procedure is remarkably sensitive, it
only examines disruptions to aspects of executive memory. Thus, it is unclear from the
aforementioned ALCR study whether or not the 7PA2 CM solution would have produced
disruptive effects to other aspects of memory commonly seen in AD sufferers, such as
aspects of long-term memory like spatial (i.e., episodic) memory.
The Morris Water Maze
The Morris water maze was developed by the neuroscientist Richard Morris to
examine spatial memory in rodents (1982). This maze consists of a large round tub of
opaque water, usually made white with powdered milk, so that the animal cannot see
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through the water to locate one of the two small hidden platforms placed 1-2 cm under
the surface (Figure 4). The pool is usually 4 to 6 feet in diameter and 2 feet deep. To
examine spatial learning, external visual cues, such as colored shapes, may be placed
around the maze to help guide behavior. There is also a side wall above the water to
prevent the rat from being distracted by laboratory activity. When released, the rat swims
around trying to find a platform. The researcher can record various measures like the
amount of time spent in a particular area of the pool, latency to reach platform, and total
distance swam. If the rat does not find a platform within 1 or 2 minutes, it is rescued.
The Morris water maze can measure various aspects of short- and long-term memory,
both of which are implicated in memory impairments associated with AD.

Figure 4. The Morris Water Maze.
The maze consists of a large round tub filled with opaque water. The animal begins
on the starting platform and this platform is released which forces the animal to swim
in order to locate the end platform.
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In 2006 Lesne and colleagues used the Morris water maze to examine the
cognitive performance of rats who had received injections into the lateral ventricles of a
soluble Ap complex. The researchers had identified a specific complex of soluble Ap
oligomer called Ap* (abeta star). This complex was shown to be negatively correlated
with cognitive performance in the APP over-expressing Tg2576 mouse model of AD.
The injections disrupted performance in the Morris water maze, suggesting a disruption
to spatial reference memory (Lesne et al., 2006). In 2007 Huang, Liang, Chen, Chen and
Hsieh-Li used the Morris water maze to examine the effects of intra-hippocampal
injections of Api^o on the performance of hyperglycemic mice. These researchers also
found that the injections disrupted spatial learning and memory (Huang et al., 2007).
The Radial-Arm Maze
Maze preparations, in general, are particularly well suited for the study of spatial
memory in laboratory animals, and understanding such behavior can advance our
understanding of cognitive processes (Olton, 1979). The radial-arm maze (RAM) has the
advantage of allowing the researcher to arrange the procedure so that both working and
spatial reference memory may be assessed separately (Wenk, 2007). The RAM is one of
the most commonly used mazes and is useful for analyzing cognitive processes of
rodents, especially Sprague-Dawley rats (Boast, Walsh, & Bartolomeo, 2000). The RAM
was originally designed by Olton Samuelson in 1976 to examine spatial learning and
memory in the rat, but has since been used to examine the cognitive processes of a
variety of other species including mice (Bane, 1997), gerbils (Maurer, Storch, LaForge,
& Boast, 1995) and humans (Aadland, Beatty, & Maki, 1985). The RAM can be used to
examine working memory, a type of memory in which representations of previously
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experienced events or episodes are temporarily maintained, as well as spatial reference
memory, a type of memory that contributes to the performance of well-learned responses
in the presence of an appropriate discriminative stimulus (Boast, Walsh, & Bartolomeo,
2000). Thus, the RAM can be used to examine aspects of both short- and long-term
memory. Since its development, the RAM has proven to be sensitive in detecting the
cognitive effects of a variety of toxicants and drugs of abuse (Levin, 1988).
The RAM (Figure 5) is usually constructed from clear plexiglass, with visual cues
at various locations throughout the maze. The apparatus generally consists of 8 arms
extending from a central chamber, however, this type of maze has been constructed with
as many as 48 arms (Cole & Chappell-Stephenson, 2003). In the normal RAM
preparation, the animal is placed in the center of the maze and allowed to enter each
baited arm to obtain a small piece of food (usually cereal). The center of the platform can
be sectioned off in order to isolate the animal from going down any or all of the arms.
This partitioning-off of the maze arms can be done manually or may be automated, and
such experimental preparations are often used for RAM procedures involving delays.
Training generally involves habituation to the RAM (which may or may not include
shaping). Open-arm training occurs next, followed by blocked-arm training (if blocks are
to be used). If a delay is required, the delay is implemented after blocked-arm training,
and finally experimental testing can begin. Training criterion may be a set number of
trials, or may be related to subject performance (e.g. less than or equal to 2 errors per
session for 3 consecutive days). Subjects are usually food deprived prior to training and
experimental sessions to increase motivation to perform. To minimize odor cues mazes
should be wiped down with an ethanol solution between test sessions (Boast et al., 2000).
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Figure 5. The Eight-Armed Radial Arm Maze (RAM).
Visual depiction of the eight-armed RAM with the subject in the starting position
facing arm 1.
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The RAM is a spatial analogue to operant experimental procedures and, as with
other operant-type experimental preparations, there are a variety of different RAM
procedures that can be used to fit the needs of the research situation. In a match-tosample (MTS) free-choice arrangement all arms will be open, but only some arms will
contain food. The same arms will always be baited throughout the study, and this
arrangement is designed to test long-term memory. The simplest arrangement is the nonmatch-to-sample (NMTS) free-choice procedure in which an animal is free to select any
arm, initial entries are rewarded with food, and no delay imposed. By imposing a delay
researchers can examine short-term working memory, and during these delay periods
animals are either confined to the central chamber or removed from the maze entirely. In
a delayed-match-to-sample (DMTS) free-choice version of the RAM some arms are
baited and some are not. A delay is imposed and, following the delay, the subjects must
visit the arms which were previously reinforced during pre-delay (Young, Stevens,
Converse, & Mair, 1996). In a delayed non-match-to-sample (DNMTS) free-choice
arrangement the animal freely visits a subset of the total arms (e.g. 4 of the 8 arms).
Next, a delay is imposed and then, following the delay, the animal is allowed to visit all
of the arms but only those arms which were not visited during pre-delay now contain
food (Porter & Mair, 1997). In contrast, in the DNMTS forced-choice procedure the
subject visits a subset of the arms which are open and contain food, and the remaining
arms are blocked. A delay is then imposed and, following this delay, all eight arms are
open but only those previously blocked arms now contain food.
The present study uses this type of DNMTS forced-choice arrangement, however,
a wide variety of RAM arrangements have been used in the past to examine aspects of
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memory and cognitive performance. Animal assays, such as the RAM, provide
researchers with a means to study the effects of certain variables which may otherwise be
unethical or impractical using human preparations. These studies may even be helpful in
determining the roles which certain stimuli play in the development of neurodegenerative
diseases like AD. One of the most prominent symptoms of AD is the progressive loss of
short-term working memory, and this is correlated with the accumulation of large
amyloid plaques and neurofibrillary tangles in the hippocampus and other areas of the
brain important to memory (Selkoe, 1991). Although such discoveries are exciting, it is
not possible to experimentally manipulate such variables using human subjects, but nonhuman experimental preparations can be used. Furthermore, the RAM has proven to be
an effective means to examine a variety of stimuli as they relate to memory and
performance in non-human animal subjects.
There are many examples of research which demonstrate the utility of the RAM
procedure as a tool to examine the effects of different variables on the memory of
laboratory animals, with the intention of telling us something about human conditions
like brain injury or neurodegenerative diseases. For example, a study by Li, Kim,
Ichikawa and Meltzer (2003) sought to determine the effects of repeated administration
of phencyclidine (PCP) on working/spatial memory performance in rodents (both rats and
mice) using an eight-armed RAM. PCP is a drug which has been reported to produce
psychosis in normal volunteers and exacerbate psychosis in schizophrenic individuals.
Therefore, an animal model of working memory impairment paralleling the deficits found
in schizophrenia would be valuable in studying the pathophysiology of schizophrenia.
Although this study failed to demonstrate that repeated administration of PCP to rodents
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produces enduring memory impairment, the experimental arrangement used to conduct
their research is of interest to the present analysis.
Li and colleagues first shaped the rodents for 5 days by placing them in the center
of the platform and allowing them to explore, and then gradually restricting the pellet
location to closer and closer to the food cups at the end of each arm. After shaping was
complete they then began the eight-arm baited RAM training. The rodent would be
placed at the center of the RAM and allowed to access all 8 baits. A 10-second delay was
introduced after each choice, during which time the rodent would be confined to center
platform. After seven days of training this delay was increased to 60-seconds, and on the
16th to 18th trial it was further increased to a 120-second delay. To be included in the
PCP test phases that followed training, all rodents had to meet a pre-defined performance
criterion of one or less re-entries into an already visited arm per session, and fewer than
two total errors for three consecutive sessions.
When a RAM memory assay seeks to examine memory by implementing a delay,
the delay need not occur following each response, and the animal need not be restrained
within the maze itself during the delay period. For example, Chrobak, Hanin, Lorens and
Napier (1995) used an experimental RAM preparation with rats with a delay procedure
very different from that arranged by Li et al. (2003). Following a 5-day habituation
period, and 25 days of open-arm RAM training, the researchers began the DNMTS
forced-choice RAM procedure in which a delay was imposed during the 4th and 5th
choices. Initially during this phase, the rat was placed inside an eight-armed RAM that
had 4 of the 8 arms blocked off. After the rat had visited the fourth available arm, the rat
was removed from the maze and returned to their home cage during the 1-hour delay
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period. During this time the researchers rotated the maze between 90 and 180 degrees.
Then, following the delay, the rat was placed back into the maze that now had all arms
open, but only those arm that were previously blocked contained food.
Using this experimental preparation, the researchers collected data on four
dependent measures: (1) the number of correct choices during the first four post-delay
choices; (2) retroactive errors, or the number of post-delay choices that were entries into
pre-delay chosen arms (those which had been open during pre-delay); (3) proactive
errors, or repeated entries into post-delay arms (i.e. a rat enters an arm which was blocked
during pre-delay, more than once during post-delay); and (4) the latency of choices
during post-delay. The combination of arms which would be blocked during the predelay sessions varied quasi-randomly among a fixed set of 20 combinations. In this study
the researchers used a within-subjects experimental design to determine the effects of
aging, thus, each rat was tested at 6,12 and 18 months of age (Chrobak et al., 1995). The
general research strategy that they used appears to be useful for examining the effects of
drugs, aging and neurodegeneration on short and long-term memory, and was used in the
present study.
Alzheimer's Research using the RAM. The RAM has also been used to
demonstrate memory impairments induced by AP25-35 (Holscher et al., 2007;
Stepanichev, Moiseeva, Lazareva, Onufriev, & Gulyaeva, 2003; Stepanichev, Zdobnova,
Zarubenko, Lazareva, & Gulyaeva, 2006). Holscher and colleagues (2007) used an eightarmed RAM to examine the effects of intracerebroventricular (ICV) injections of AP25-35
on both short-term working and long-term memory. A control group received similar
injections which did not contain the active compound. Control groups are oftem used to
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ensure that the deficits in memory are due to the compound of interest and not simply the
result of the stressful injection process, since stress has been shown to interfere with
memory in rats (Baker & Kim, 2002). The researchers used a MTS free-choice
arrangement in which 3 of the 8 arms were always baited, and no delay was imposed. An
error in working memory was said to occur if a rat visited an arm during the same session
which was baited, but had already been visited during that session. Visits to arms that
had never been baited were considered long-term memory errors. The researchers found
that the injections produced significant impairments in both short-term working memory
and long-term memory, but these effects were reversible (Holscher et al., 2007).
Stepanichev and colleagues (2003) used an eight-armed RAM to examine the
effects of stereotaxic injections of AP25-35 on spatial and working memory in rats using a
NMTS free-choice arrangement. Under this arrangement all eight arms in the maze are
open and baited. A rat is placed into the maze and allowed to visit all eight arms, with no
delay imposed. After the response is well-learned the subjects are divided into two
groups. The control group received a single vehicle injection and the experimental group
received an injection of the AP25-35 compound. The rats were again tested 60 days after
the compound or vehicle solution was administered, and there were no differences in the
two groups. From these results the researchers concluded that AP25-35 had no effect on
memory (Stepanichev et al., 2003).
In 2006 Stepahnichev and colleagues used a MTS free-choice RAM preparation
to once again test the effects of one injection of the AP25-35 compound on the long-term
and short-term working memory of rats. Unlike the previous experiment, only five of the
eight arms were baited. The sequence of which five arms would be baited differed for
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each individual rat, but was held constant throughout the study. Unlike the previous
experiment, the rats did not learn the task until 4 weeks (recovery period) and 2 days
(food-deprivation period) after the each rat had already had the surgery and received the
single injection of either vehicle or AP25-35. The experimental group showed statistically
significant differences with regards to errors when compared to the control group.
Furthermore, when the animals were sacrificed following the experiment, the researchers
found that the number of errors made on testing days negatively correlated with the
number of nerve cells in the hippocampal field CA1. These results suggest that
impairments in learning and memory can be induced by a single administration of AP2535, and that these impairments are associated with neurodegenerative changes in the
hippocampal field CA1 (Stepahnichev et al., 2006).
The RAM procedure has also been used with rats to demonstrate memory
impairments induced by exogenous AP1-40 (Hashimoto et al., 2002; Hashimoto et al.,
2005; Sweeney et al., 1997). Sweeney and colleagues (1997) examined the effects of
bilateral intrahippocampal injections of AP1.40 on rat performance in a RAM foraging
task. The researchers used a DNMTS free-choice arrangement in which AP1.40 was
administered immediately before the test session began, and a 30-minute delay was
imposed between the 4th and 5th choices. The researchers chose to give the injections
immediately prior to the beginning of each test session to ensure that the performance
decrements were actually the result of the Api.40 compound itself, and not simply the
result of the injection or the stress of the injection process. Interestingly, the injections
had no effect on pre-delay choices, but had a significant effect on post-delay choices.
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The results of this study suggest that Api^o does have acute effects on short-term memory
and may play a significant role in some memory deficits seen in AD.
In 2002 Hashimoto and colleagues used an avoidance learning task to determine
the effects of docosahexaenoic acid (DHA), a major n-fatty acid, on the memoryimpairing effects of cerebral ventricle infusions of APi^o peptide. As expected, the
infusions did produce impairments in learning and memory. The researchers determined
that DHA had protective and restorative effects (Hashimoto et al., 2002). In 2005
Hashimoto and colleagues examined these same variables using a MTS free-choice
arrangement in an eight-armed RAM and found similar results. Specifically, the
researchers found that ventricle infusions of the ApMo peptide produced impairments to
both short-term working memory and long-term (reference) memory, and that DHA once
again had protective and restorative effects (Hashimoto et al., 2005).
In 1997 Sweeney and colleagues examined the effects of bilateral
intrahippocampal injections of |3A4 on the performance of rats in a DNMTS free-choice
RAM foraging task, with a delay imposed following the 4th choice. The primary core of
the amyloid plaques seen in AD individuals is the pA4 peptide. Previous research
examining the effects of PA4 on performance in a classic RAM had given injections 30
minutes before the test sessions concluding that, although the compound had no effect on
this short-term memory task, it did interfere with long-term retention (McDonald et al.,
1994). Sweeney and colleagues felt that in the previous study, not only was the drug
administered too long before the test session, but also that the delay between the 4th and
5th choices was too long (i.e., effects of PA4 injections may have worn off). This
discrepancy, they hypothesized, might account for the absence of an effect.
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To rectify this, Sweeney and colleagues administered 0A4 immediately before
each test session, and imposed only a brief 30-second delay between the 4th and 5th
choices on the RAM free-choice task in rats that had been food-deprived to 90% of their
free-feeding weight. During the procedure all eight arms were baited, injections were
delivered immediately before each test session, and rats were placed into the maze facing
a different arm each session. After the 4th choice a 30-second delay was imposed during
which time the rat was taken out of the maze and placed in a carrier for 30 seconds. Then
the rat was then returned to the central platform and entries into unvisited arms were
considered correct choices, whereas, entries into already visited arms were considered
errors. The rat must travel greater than or equal to the length of 53 cm down any one arm
for and entry/choice to be recorded. The session was terminated when either: (a) all 8
food pellets had been consumed, (b) 10 choices had been made, or (c) 5 minutes had
elapsed, whichever occurred first. Injections were delivered into the hippocampus,
through a cannula in the skull. Vehicle injections were also given to ensure that
performance-effects were not due to simply giving the injection.
Results of this study indicate that p\A4 injections did increase errors immediately
following the delay (i.e. for choice # 5), which suggests that there is an effect on shortterm memory. Although the researchers concluded that p\A4 does have acute effects on
memory-based performance, these effects may be short-lived. In fact, the injections
themselves may have made the rats more susceptible to interference, because
performance on choice 6 was comparable to that of choice 4 suggesting that the feedback
provided from choice 5 (correct or incorrect) was enough to reinstate the animal's
proficient performance. This suggests that some memory of the choices 1-4 must have
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been available, which would not be the case had the impairment been one of learning and
retention. The detrimental effects of PA4 were both acute and transient but not,
therefore, due to an aggregative neurodegenerative processes (Sweeney et al., 1997).
The earliest features of AD include impaired memory for recent events, followed
by deficits in spatial learning and memory (Gottfries, 1995; Kalman, Magloczky &
Janka, 1995). When compared to healthy volunteers, patients with AD will show a
delay-dependent reduction in choice accuracy under a visual DMTS task and this is
thought to be indicative of impaired short-term working memory (Ballard & McAllister,
1999). Of all of the aforementioned procedures, the delayed non-match-to-sample
(DNMTS) procedure is the best experimental RAM preparation to examine both shortterm working and long-term (i.e., spatial) memory. Under this procedure rodents are first
allowed to visit a subset of the arms, are then removed or prevented from responding for
some period of time (delay), and are then allowed to visit the remaining arms. The
present study used a DNMTS forced-choice procedure in which a delay was imposed
between the 4 th and 5th choices to examine the effects of Ap oligomers on memory.
Rationale for the Present Study
Post mortem neuropathology of AD sufferers reveals the presence neuritic
plaques, which are mainly composed of large extracellular aggregates of Ap, as well as
the presence of NFTs. Accordingly, most AD research conducted in recent years has
focused on these two types of proteinaceous brain inclusions. Specifically, research has
tended to examine amyloid plaques and the synthesis, cleavage, and deposition of Ap.
The genetic mutations associated with inherited AD involve genes linked to APP and Ap
synthesis (Walsh & Selkoe, 2007). Data from transgeneic mouse models of AD have
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shown that memory loss is poorly correlated with the presence of NFTs, and evidence
suggests that NFT formation follows amyloid deposition (SantaCruz et al., 2005).
Furthermore, total plaque burden does not correlate with the progression of cognitive
decline associated with AD, casting further doubt on the importance of these large
extracellular plaques in the development of the disease (Braak & Braak, 1998).
The early memory loss associated with AD may be better explained by the
presence of small soluble forms of Ap, than by the presence of NFTs or large aggregated
amyloid plaques (Walsh & Selkoe, 2007). The concept of small soluble forms of Ap was
advanced in 1995 by Oda and colleagues. Other researchers went on to demonstrate that
these small soluble forms of AP could be formed synthetically (Lambert et al., 1998;
Klein et al., 2001). In 2002 Walsh and colleagues demonstrated that Chinese hamster
ovary cells (CHO) transfected with a familial AD-linked human mutant APP (valine to
phenylalanine at position 717, near the y-secretase site) over-express AP oligomers in the
culture medium. Conditioned media (CM) from these cells are called 7PA2 cells and
these have been shown to disrupt rat hippocampal long-term potentiation (LTP), which is
a cellular process often used to model short-term memory formation (Walsh et al., 2002).
Although researchers have demonstrated a correlational relationship between poor
memory/cognitive performance and levels of oligomeric Ap in the brain, very few true
experiments have examined the cognitive effects of Ap oligomers. A true experiment
requires an experimental procedure (i.e., behavioral assay) which has proven efficacy for
examining the target response in the population of interest. The ALCR procedure is one
example of such an experimental assay. Developed by Weldon and colleagues in 1996,
the ALCR procedure has proven to be a remarkably sensitive experimental assay which
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can be used to examine the effects of Ap oligomers on the reference memory of rodents
(Weldon et al., 1996). Although several studies (O'Hare et al., 1999; Richardson et al.,
2002; Townsend et al., 2006) have used this procedure to demonstrate the disruptive
effects of Ap oligomers on the reference memory of rodents, the remarkable sensitivity of
the ALCR procedure may hinder the generalizability of these findings to other types of
memory, aside from reference memory. Furthermore, although the ALCR procedure is a
good test of executive functioning, there are far better experimental assays which are
proven to measure various other types of memory relevant to AD, and the RAM is one
such example.
Due to the limitations of the ALCR procedure, there is a need for studies which
use other well-established experimental assays proven to measure aspects memory and
cognitive performance in order to examine the effects of Ap oligomers on different types
of behaviors associated with AD dysfunction. An advantage of the RAM is that it is a
highly adaptable preparation which can be altered to fit the needs of the research
situation. In addition, the RAM is well-established as an experimental assay designed to
examine various types of memory in rodents, especially spatial and short-term working
memory. Furthermore, the RAM can be used to assess both working and reference
memory separately, and delays can be imposed so that researchers may examine both
short-term and long-term memory. The RAM is a very well-established experimental
assay of memory which was used in the present study to examine the effects of Ap
oligomers on the cognitive performance of rodents in the hopes of advancing AD
research.
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METHODS
Subjects
Twenty-five male Sprague-Dawley rats purchased from Charles River (Portage,
MI) were used as subjects. The subjects were approximately 1 year old at the beginning
of the study, with an average weight of 448 grams, and had been handled extensively
prior to the start of the study. Throughout the study the subjects were given unlimited
access to water and were housed individually in plastic cages (24 cm long x 31.5 cm wide
x 21 cm high) with metal grated tops. The subjects were housed in an animal colony
room in Haenicke Hall at Western Michigan University. The colony room was
maintained on a 12-h light/12-h dark cycle and kept at a constant temperature of 20-22°C
and a constant humidity of 24%. Following surgery the rats were housed in a similar
manner, except that the lids of the cages were changed to elevated tops to allow sufficient
room for the animal's head cap and guide cannula.
Throughout the experiment the rats were weighed daily and were maintained at
85% of their free-feeding weight by limiting their access to Purina Rat Chow (RalstonPurina, St. Louis). Enough food which would be sufficient to maintain the desired
weight was delivered immediately after the final experimental sessions for that day had
concluded, and this usually occurred about 20 hours before the first experimental session
of the following day. This study was approved by the Institutional Animal Care and Use
Committee at Western Michigan University and was conducted in accordance with the
Guide for Care and Use of Laboratory Animals promulgated by the National Research
Council (1996).
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Apparatus
The experiment was conducted in an isolated room in Haenicke Hall with direct
and private elevator access to the animal colony. The experimental apparatus was an
eight-arm radial arm maze constructed of clear plastic. The walls of the maze were 18
cm high and each arm was 60 cm long and 12 cm wide. The arms radiated symmetrically
outward from a circular start box which was 36 cm in diameter (see Figure 5, p. 23).
Each arm was covered by a hinged plastic top which could be opened for easy cleaning.
At the end of each arm was a small food cup which could be baited with various types of
small edible food. Cocoa Pebbles cereal (Post Cereals, Battle Creek, MI) were used to
bait the arms in this study.
The design of the maze was such that any or all individual arms could be
blocked using plastic partitions which slid into the intersection between the start box and
the individual arm entrance. The maze sat atop a perforated metal, and papers were
placed beneath the floor to collect any feces or urine. The maze was encased by four
opaque walls in order to prevent outside visual distractions. To provide visual cues for
the rat, eight pieces of white poster board containing different designs in black ink (e.g., a
straight vertical line, three squiggly horizontal lines) were affixed to the opaque walls
surrounding the maze, and were located immediately behind the ends of each of the eight
arms. The criteria for recording a choice or entry required that the rat run at least 53 cm
down the arm, and this distance was marked by a clearly visible line scribed on the floor
and sides of each arm.
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Behavioral Procedures
All training sessions generally were conducted 6 days a week, at about the same
time each day during the light portion of the light/dark cycle. Figure 6 shows an outline
of entire experiment as it occurred. All sessions were observed and scored by a
researcher and were video recorded as well. The researcher also timed each individual
trial using a digital stop watch, and these data were also recorded. Data were recorded on
specially created data sheets (Figure 7). The phase of the study (e.g.,
Acclimation/Shaping phase) and the day (e.g., day 1) was listed at the top of the data
sheet, and the subject (e.g., Rat 1) was also listed. There was a space to record the total
number of errors made and the time (i.e., duration). If blocks were used during a
particular phase, the researcher would physically draw in the locations of the blockedarms on the data sheet before the beginning of each session. This allowed the researcher
to then go back and determine what type of errors had been made and to record this data
at the end of each test session.
Habituation/Shaping
The habituation/shaping procedure occurred over the course of five days and was
intended to familiarize the subjects to both the food reinforcer and the testing situation.
On the first day of the habituation/shaping phase the food reinforcer was introduced to
the subjects by simply placing a small handful of the cereal into the individual home
cages of each rat. This was done to give the subjects experience with the novel food
reinforcer. On day two of the habituation/shaping procedure the subjects were each
individually placed inside the open maze and Cocoa Pebbles were scattered at the base of
each arm (closest to the start box). Each rat was allowed to roam the baited maze
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Dissertation
Day Activity

Description

Schedule
Day Activity

Description

1

Acclimation to SR+

pellets in home cage

41 Surgery Day

2
3
4
5

Aclimation/ Shaping
Aclimation/Shaping
Aclimation/ Shaping
Aclimation/ Shaping

pellet at base of arm
pellet 1/3 way down
pellet 2 / 3 way down
Pellet at end of arm
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44
45
46

6

Open-arm Training

all arms open & baited

47

7
8
9

Open-arm Training
Open-arm Training
Open-arm Training

all arms open & baited
all arms open & baited
all arms open & baited

48 Post-Surgery Retraining
49 Post-Surgery Retraining
50 Post-Surgery Retraining

blocked arms = 1,3,4,7
blocked arms = 1,2,5,7
blocked arms = 1,3,5,8

10 Open-arm Training

all arms open & baited

51 Testing Day: 7PA2, CHO

blocked arms = 2,3,4,8

all arms
all arms
all arms
all arms
all arms
all arms
all arms

52
53
54
55
56
57
58

blocked
blocked
blocked
blocked
blocked
blocked
blocked

11
12
13
14
15
16
17

Open-arm
Open-arm
Open-arm
Open-arm
Open-arm
Open-arm
Open-arm

Training
Training
Training
Training
Training
Training
Training

18 Open-arm Training
19 Open-arm Training
20 Open-arm Training
21
22
23
24

Delay
Delay
Delay
Delay

curve=
curve=
curve=
curve=

5 min
30 min
2 hr
5 min

25 Delay curve= 30 min
26 Delay curve= 2 hr
27
28
29
30
31

Blocked-Arm
Blocked-Arm
Blocked-Arm
Blocked-Arm
Blocked-Arm

Training
Training
Training
Training
Training

open
open
open
open
open
open
open

& baited
& baited
& baited
& baited
& baited
& baited
& baited

= 2,3,7,8
= 3,5,6,8
= 1,3,6,8
= 1,3,4,6
= 2,4,5,8
= 1,5,6,7
= 2,4,7,8

blocked arms = 1,5,6,8
blocked arms = 3,4,7,8
blocked arms = 2,3,6,8

blocked
blocked
blocked
blocked

62
63
64
65

blocked
blocked
blocked
blocked

arms
arms
arms
arms

= 1,3,5,6
= 2,4,6,7
= 3,5,7,8
= 3,5,6,7

Blocked-Arm Training
Blocked-Arm Training
Blocked-Arm Training
Testing Day: 7PA2, CHO

arms
arms
arms
arms

= 2,3,4,7
= 1,3,4,5
= 1,4,5,7
= 1,4,5,6

blocked arms = 3,4,6,7
blocked arms = 1,4,6,8

66 Blocked-Arm Training
67 Blocked-Arm Training

blocked arms = 1,2,5,8
blocked arms = 2,4,7,8

blocked
blocked
blocked
blocked
blocked

68
69
70
71
*72

blocked
blocked
blocked
blocked
blocked

arms
arms
arms
arms
arms

= 1,2,4,7
= 2,3,5,8
= 3,4,6,8
= 1,3,4,6
= 3,4,6,7

blocked arms = 1,2,4,6
blocked arms = 1,2,4,5

35 Blocked-Arm Training
36 Blocked-Arm Training

blocked arms = 2,3,6,7
blocked arms = 1,2,4,8

Training
Training
Training
Training

arms
arms
arms
arms
arms
arms
arms

59 Blocked-Arm Training
60 Blocked-Arm Training
61 Blocked-Arm Training

33 Blocked-Arm Training
34 Blocked-Arm Training

Blocked-Arm
Blocked-Arm
Blocked-Arm
Blocked-Arm

Blocked-Arm Training
Blocked-Arm Training
Blocked-Arm Training
Blocked-Arm Training
Blocked-Arm Training
Blocked-Arm Training
Testing Day: 7PA2, CHO

all arms open & baited
all arms open & baited
all arms open & baited

32 Blocked-Arm Training

37
38
39
40

***Recover Occuring
During this
Period of Time***

blocked arms = 2,5,7,8

blocked
blocked
blocked
blocked

arms
arms
arms
arms

Blocked-Arm Training
Blocked-Arm Training
Blocked-Arm Training
Blocked-Arm Training
Testing Day: 7PA2, CHO

arms
arms
arms
arms
arms

= 3,6,7,8
= 2,3,5,6
= 2,3,5,7
= 1,2,6,8
= 1,2,5,6

*** 5 Days of recovery***
Testing Days = Infusions Delivered
*By this point in the study the majority of the
subjects had non-functional skull caps

= 1,4,7,8
= 4,5,7,8
= 1,4,6,7
= 1,3,6,7

Figure 6. Outline of the Dissertation Running Schedule.
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Acclimation/Shaping-Day 1

Rat 1
Total Errors =

Rat 3
Total Errors =

Time=

Rat 2
Total Errors =

Time

Time=

Rat 4
Total Errors =

Time

Figure 7. Example of the Data Sheets Created for this Study.
The phase of the study and day are listed at the top of each sheet. The subject number
is listed in the lower left hand corner of each maze depiction. This specific example
is from the Acclimation/Shaping phase for rats 1, 2, 3, and 4.
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freely for 5 minutes. The rat was then removed, and the maze was wiped down and
baited for the next subject. The third day of habituation/shaping was similar to the
second day, expect that the food pellets were placed about 1/3 of the way down each arm.
On the fourth day the food pellets were placed 2/3 of the way down the arm. Finally, on
the fifth and final day of the habituation/shaping procedure the pellets were placed in the
food cups at the end of each arm. Thus, while the rats were being habituated to the test
situation, they were simultaneously being "shaped" to move further and further down
each arm to obtain the food reinforcer.
Open-Arm Pre-Training
Open-arm pre-training sessions occurred daily over the course of 15 consecutive
sessions, immediately following the habituation/shaping procedure. During the open-arm
pre-training sessions all of the arms were open and baited. The session termination
criteria required that the subjects would remain in the maze until either all 8 pellets had
been consumed or 10 minutes elapsed, whichever occurred first. The subject was placed
in the start box facing the same direction (arm 1) each time (see Figure 5). The timer was
started as soon as the rat had been placed into the starting position. During this training
procedure data were collected and recorded for the total response duration (e.g., 2:04 = 2
minutes and 4 seconds), the total number of errors (e.g., 4 errors), and the total number of
correct responses occurring within the first eight responses (e.g., 6/8 correct). The
average time required to complete the maze was 2:39 during open-arm pre-training
session 1, and this time was reduced to 0:51 by the 15 session. The group mean for the
total number of errors decreased from 2.08 errors during session 1, to 1.04 errors by the
15th session. The number of correct responses out of the first 8 responses rose from 6.8
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correct to 7.4 correct between the first and last open-arm pre-training sessions. Guided
by these performance improvements, training was able to progress to the more difficult,
blocked-arm procedures.
Blocked-Arm Training
For blocked-arm training with a delay the plastic partitions were placed at the
entrance of four of the eight arms of the radial arm maze. The sequence of arms that
were blocked was chosen randomly from a grab bag which contained almost all the
possible combinations printed on square cards. Combinations that included every other
arm (e.g., 1,3,5,7 or 2,4,6,8) and those that included four arms in a row (e.g., 1,2,3,4 or
5,6,7,8) were excluded from the list of potential combinations which could be used. Each
day the researcher would pull one combination from the bag, and this combination would
be used for all of the rats that day. After a combination had been used, it was thrown out
and no combination was ever used more than once.
During blocked training the subject was first placed in the starting position and
allowed to visit the four unblocked arms which were baited with food. If the rat
performed this sequence perfectly, each arm would only have been visited one time.
Revisiting an already visited arm during this initial session was counted as an incorrect
response. Once all four arms were visited the subject was removed from the maze for a
designated period of time (delay). During the delay the researcher removed the partitions
from the previously blocked and baited those arms. The arms which had just been visited
were unbaited, and only those previously blocked arms now contained food. Following
the delay, the subject was placed back into the maze and allowed to obtain the food
reinforcers from the four previously-blocked arms.
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Dependent Variables
There are two types of errors that could occur during post-delay sessions. The
first type, retroactive errors, occurred when the subject visited an arm that was open
during the pre-delay session and, therefore, was not baited during post-delay session.
The second type, proactive errors, occurred when a subject visited an arm that was
blocked during the pre-delay sessions more than once during post-delay session.
As Poling and Byrne (2000) discuss, it is well established that drugs and other
perturbations typically disrupt responding to a greater extent when stimulus control is
relatively weak than when it is relatively strong. In other words, errors are more common
when stimulus control is weak and less common when stimulus control is strong. Prior to
the start of testing with 7PA2, different delays were examined to determine a value at
which retroactive errors exceeded proactive errors. Both are assumed to be measures of
"spatial working memory" (Chappell, McMahan, Chiba, & Gallagher, 1998). Essentially,
the different delay durations were examined to determine whether or not the duration of
the delay affected stimulus control.
Assessment of Various Delays
Three different delays were examined: 5 minutes, 30 minutes, and 2 hours. The
data for the delay-accuracy curve were collected over the course of 6 days. The 5-minute
delay was examined on days 1 and 4, the 30-minute delay was examined on days 2 and 5,
and the 2-hour delay was examined on days 3 and 6. Pre-delay data were collect on the
number of correct and incorrect entries in the first four arms. Post-delay data were
collected on both retroactive errors and proactive errors. Data were also collected and
recorded for the total number of errors across the entire session (i.e., pre-delay and post-
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delay errors combined). The group means for the different variables examined proved to
be similar across the 5-minute, 30-minute, and 2-hour delay durations, and at all of these
values the number of retroactive delays exceeded proactive delays. The 2-hour delay was
ultimately chosen for practical reasons (i.e., it allowed for easier sequential testing of
subjects).
After the 6 days of blocked-arm training to determined delay curve, blocked-arm
training continued for another 14 days using the chosen 2-hour delay interval. The 14day group average for correct entries and errors in the first four entries during the predelay period are shown in Figures 8 and 9, respectively. The 14-day group mean for
post-delay retroactive and proactive errors are shown in Figures 10 and 11, respectively.
These data demonstrate the stability of responding and provide visual support for the
researchers' decision to move on to the next phase in the research process and to schedule
the surgeries.
Surgical Procedures
Prior to receiving any anesthesia, the rats were first given intraperitoneal (IP)
injections of 1 mg/kg atropine to prevent bradycardia (i.e., slowed heart rate), which can
sometimes result from anesthetization. Next, the rats were anesthetized via IP injections
with 50 mg/kg sodium pentobarbital. Full anesthetization was indicated by the absence
of the hind-paw pinch reflex. Once the rat was fully anesthetized a unilateral guide
cannula (C313G, 22 gauge, Plastics One, Roanoke, VA) was surgically implanted into
the dorsal lateral ventricle at stereotaxic coordinates of AP = - 0.4, ML = + 1.3, DV = 4.2 (Paxinos & Watson, 1998) and anchored to the skull with skull screws and
cranioplastic cement.

Figure 8. Mean Correct Entries Made of the First Four Pre-Delay Entries.
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Figure 9. Mean Errors of the First Four Pre-Delay Entries.
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Post Delay: Average Retroactive Errors
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Figure 10. Mean Retroactive Errors.

Post Delay: Average Proactive Errors
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Post Surgery Recovery and Retraining
Immediately following the surgeries the rats were returned to their individual
home cages and allowed to rest for five days. The rats had fully recovered after five days
of rest, and then post-surgery retraining began. Post-surgery retraining was done to
ensure that the surgeries did not affect maze performance. After three days of retraining
no differences were identified between pre- and post-surgery maze performance. The
assessment of post-surgery maze performance was critical to the internal validity of the
study because, without this assessment, one could not reliably distinguish between effects
on performance due to the independent variable and those resulting from the surgery.
Injection Materials
The rats were given injections of either 7PA2 or vehicle control via their
implanted guide cannulas. Concentrations of soluble Ap oligomers that are
physiologically relevant to that found in human brain (<10"9 M) are contained in the
culture media (CM) of Chinese Hamster Ovary cells (CHO) transfected with a human
mutation of APP that causes early-onset AD (Podlisny et al., 1995). These cultured cells,
called 7PA2 cells, excrete Ap oligomers, primarily dimers and trimers, into the CM as the
cells mature. The vehicle control, CHO-CM, contains extracellular components similar
to those found in the 7PA2 CM, but without the Ap oligomers. The 7PA2 and CHOwere obtained from Dr. Sylvain Lesne, an expert in the production of oligomers of
amyloid-p from the University of Minnesota (e.g., Lesne et al., 2006).
Injection Procedures
As was previously mentioned, no sessions were arranged for eight days
immediately following cannula implantation surgery. Following the five days of
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recovery and three days of retraining, one session was conducted each day, as described
above. Immediately after the pre-delay part of the session ended, all of the rats received
an intracerebroventricular (ICV) injection of either 7PA2 CM or CHO- CM (n = 10 per
group, with rats randomly assigned to the 7PA2 and CHO- groups). Two hours after the
injection, they began the post-delay portion of the daily (test) session, as described
previously. The two-hour delay between injection and post-delay test session has
previously been shown to produce errors under the ALCR procedure (Cleary et al., 2005).
Micro-infusion pumps (CMA/100, CMA, Stockholm, Sweden) were used to slowly
infuse 20 ul of 7PA2 CM or CHO- CM slowly through 28 gauge injectors (C313I,
Plastics One) into the lateral ventricle at a maximum rate of 5 ul/minute.
The initial test session under 7PA2 and CHO- CM was followed by 3 weeks of
training and testing sessions (see Figure 6). During this time both the 7PA2 group and the
CHO- group received 6 days without any injections, followed by 1 day with an ICV
injection prior to the second part of the daily session. Animals that received 7PA2 CM
initially always received 7PA2 CM in subsequent injections and animals that initially
received CHO- CM always received CHO- CM subsequently. Two rats in the 7PA2
group did not receive the third injection because their cannula skull caps had loosened
and, as a result, were no longer functional. By the last test day over half of the subjects
had non-functioning skull caps, therefore, the data from this day were not included in the
final outcome of the study. Following behavioral testing, the rats were euthanized and
cannula placements were confirmed by histological examinations.
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RESULTS
The performance of the treatment (i.e., 7PA2 CM) group can be compared to that
of the control group (i.e. CHO- CM) by examining the mean (+ SEM) number of
proactive errors, retroactive errors, and total errors made by rats during the three test
sessions in which 7PA2 CM or CHO- CM was administered 2 hours earlier and
comparing these data to the data collected during the three control sessions immediately
preceding those test sessions (Figure 12). The performance of the two groups of rats
during the three control sessions immediately preceding test sessions was comparable.
Specifically, the mean control value of total errors was 2.10 for the 7PA2 group and 2.33
for the CHO- group. Each group made relatively few proactive errors (M = 0.30 and 0.33
for the 7PA2 and CHO- groups, respectively) and substantially more retroactive errors
(M = 1.80 and 2.00 for the 7PA2 and CHO groups, respectively).
In contrast to the comparable performance levels achieved by both groups during
the control sessions, performance during test sessions differed in the two groups. While
the performance of the CHO- CM group during experimental sessions was comparable to
control-session performance, the performance of the 7PA2 CM group was not. For the
CHO- CM group (i.e., the control group) the mean values for the number of proactive
(0.27), retroactive (2.0), and total (2.37) errors occurring two hours after ICV injections
of CHO CM did not differ appreciably from these control values. Statistical analysis by
means of Wilcoxon signed rank tests indicated that control and injection means for
proactive, retroactive, and total errors did not differ at the 0.05 alpha level (W = -7, -6, -9;
p = 0.56, 0.56,0.64, respectively). However, for the rats that received 7PA2 CM (i.e. the
experimental group) the mean numbers of proactive (0.57), retroactive (2.55), and total
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(3.125) errors made during sessions preceded by injections were substantially above
control levels. Wilcoxon signed rank tests indicated that the differences in means were
statistically significant at the .05 level for proactive, retroactive, and total errors (W = 28, -47, -55; p = 0.0156, 0.0137, 0.002, respectively).
Table 1 provides data for each of the three injections of CM from 7PA2 and
CHO- cells. Here, the mean number of errors emitted during sessions immediately
following injections is expressed as a percentage of the mean number of errors emitted
during the preceding control session, not preceded by an injection. These data indicate
that the disruptive effects of the Ap" oligomer-containing 7PA2 CM did not increase with
repeated exposure, but rather were largest following the first injection.

Table 1
Errors During Sessions Preceded by Injections Expressed as Percent Control

Error Type
Administration

Proactive
1

2

Retroactive

3

1

2

Total

3

1

2

3

7PA2 Group

500

150

*

223

125

135

243

129

173

CHO Group

67

100

75

139

82

127

129

84

116

*no errors were emitted during the control session
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DISCUSSION
The results of this study indicate that oligomers of amyloid-p significantly affect
the performance of rats tested in a RAM by increasing proactive, retroactive, and total
errors. Administrations of CM containing A(3 oligomers produced significant memory
impairments, whereas no such impairments in memory were produced by those
administrations of CM not containing the A(3 oligomers. These results suggest that Ap
oligomers were responsible for the observed effects on memory, and that the observed
memory impairments were not the result of extraneous factors such as the IVC injections
or non-specific components of the CM.
Ap oligomers are small clusters of accumulated P-amyloid plaques, and the
presence of these plaques in the brain is considered to be a hallmark of AD. These Pamyloid plaques are a prime suspect in AD because they are sticky fragments that tend to
accumulate in stages. The first stage is formation small clusters called oligomers, then
chains of clusters called fibrils, then mats of fibrils called sheets, and the final stage is
clumps of sheets called plaques (Alzheimer's Association, 2006). These stages are
thought to disrupt brain cells by clogging cell-to-cell communication, which activates the
immune system triggering inflammation, and ultimately resulting in cell death (Mrak &
Griffin, 2001). The evidence to support this amyloid hypothesis comes from several
sources. First, all of the rare genes which have been identified that virtually guarantee a
person will develop AD increase either the production or accumulation of P-amyloid
(Alzheimer's Association, 2006). Second, mice which have been genetically engineered
to carry the genes associated with inherited AD develop amyloid plaques and develop
symptoms which mimic those of AD sufferers (Janus et al., 2001). In addition, AP fibrils
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are known to kill neurons in a cell culture, suggesting that these fibrils might initiate AD
neurodegeneration (Klein, Grant & Finch, 2001). However, it has recently been
determined that the A(3 fibrils are not the only form of Ap relevant to AD, and that small,
pre-fibrillar assemblies of Ap (i.e., Ap oligomers) are also deleterious (Walsh & Selkoe,
2007). The present study sought to examine further the potentially causative role of Ap
oligomers in AD neuropathology.
In order to examine the role that these oligomers may have in the development of
AD, it is important to use a tried and true animal model of memory. The RAM was used
in the present study because it is a well-established animal model of spatial working
memory in rodents (Chappell et al., 1998; Chrobak et al., 1995; Levin, 1988; Olton,
1985; Wenk, 2007) that has proven to be sensitive to the effects of a variety of toxicants
and drugs of abuse (Levin, 1988). Furthermore, the RAM is useful in examining aspects
of both short- and long-term memory relevant to AD.
Cleary et al. (2005) reported previously that naturally produced Ap oligomers
from 7PA2 cells, but not AP monomers or non-Ap CM, produced cognitive impairment
in rats tested under an ALCR procedure. Ap oligomer-induced errors under ALCR have
been associated with reference memory (Cleary et al., 2005), and such errors in the
Morris Water Maze (Lesne et al., 2006) also are thought to be related to reference
memory.
Under the RAM procedure in the present study, oligomers of Ap significantly
increased proactive and retroactive errors in rats. Both measures are assumed to assess
spatial working memory (Chapell et al., 1998). Errors did not increase when CM
containing no Ap oligomers was administered. Therefore, it appears that the Ap
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oligomers per se, not ICV injections or non-specific components of the CM, were
responsible for the effect. In sum, the present data provide further evidence of the
deleterious cognitive effects of oligomers of Ap and extend those effects to a well
established animal model of spatial working memory, the RAM (Chappell et al., 1998;
Jaffard et al., 2000; Olton, 1985; Wenk, 2007). This extension is significant because a
deficit in working memory has been considered to be one of the earliest detectable
symptoms of AD and is a clinical hallmark of the disease (Selkoe, 1991; Small et al.,
2007; Walsh et al, 2005).
In the study by Cleary et al. (2005), in which rats responded under an ALCR
schedule, Ap oligomers increased perseveration errors (i.e., errors to 201% of the control
level and switching errors to 146% of control). Switching errors occurred when the
subject did not alternate to the other lever after reward or switched from the correct lever
to the incorrect lever before completing the response requirement and getting rewarded.
Perseveration errors occurred when the subject 'persevered' on the incorrect lever after
responding once on the incorrect lever. In the current study in which rats were tested in a
RAM, AP oligomers increased Proactive and Retroactive errors to 190% and 142% of
control, respectively. Thus, the degree of cognitive disruption observed under the two
behavioral procedures was comparable in magnitude.
Although they differ substantially in complexity, both the ALCR and RAM
procedures involve spatial memory, in that successful performance requires subjects to
move from place to place and to base their movements on the consequences of prior
actions. It is tempting to suggest that oligomers of Ap generally impair rats' spatial
memory, but an unpublished pilot study from our laboratory failed to find a disruptive
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effect of oligomers of Ap (ICV) in rats exposed to a delayed-nonmatching-to-position
procedure, which also involves spatial memory (Vardigan et al., 2006). It is not clear
why Vardigan et al. failed to demonstrate memory impairment, but it was the case that
the rats had received extensive training and demonstrated high levels of accuracy at all
delays. Moreover, a correction procedure, intended to reduce position bias, was in effect.
Either of these variables may have reduced the sensitivity of the procedure. Nonetheless,
Vardigan et al. did find increased errors with injections of the prototypic amnestic drug
scopolamine.
Although the current study expanded the class of behaviors affected by Ap
oligomers, the range of conditions under which memory is disrupted and the specific
nature of the disruption is still largely unexplored. It is, however, clear that the disruptive
effects of oligomeric Ap are not limited to measures of reference memory and common
animal behavior tests may be sensitive to these effects under some conditions.
The present data are consistent with those reported by Cleary et al. (2005) in that
the effects of Ap oligomers were transient, that is, there was no evidence of significant
cognitive impairment on the day following the injection under either the RAM or the
ALCR lever pressing task. Moreover, there was no evidence that oligomeric Ap was
neurotoxic in the present study, because there was no increase in errors as a result of
repeated exposure. In fact, the oligomers appeared to act similarly to pharmacological
agents that are cleared over time. This aspect of the oligomers' action is important
because it offers hope that cognitive deficits due to Ap oligomers in people with AD may
be reversible. Reversible effects were also reported in an animal model by Holscher et al.
(2007), who found that three daily ICV injections of soluble AP(25-35) produced short-
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and long-term memory impairment in rats tested in a radial-arm maze on post-injection
days 12-20, but not on post-injection days 3-11 or 20-28. The difference in the timecourse of effects with soluble synthetic AP(25-35) and with oligomers of naturally
derived AP(l-42) from 7PA2 cells is noteworthy and merits investigation with respect to
mechanism.
In sum, the present findings provide further support for the conclusion that 7PA2
cells disrupt memory and that, because there was no evidence of significant cognitive
impairment on the day following the injection, the memory disrupting effects of the Ap
oligomers are transient. Furthermore, there was no evidence of enduring neurotoxicity,
because errors did not increase as a result of repeated exposure. To the contrary,
oligomers appeared to act similarly to pharmacological agents which clear over time.
However, the range of conditions under which memory is disrupted by 7PA2 remains to
be determined, and further research in this area is certainly warranted.
Taken together, these results are both encouraging and confounding. On the one
hand, these results seem to suggest that cognitive deficits resulting from Ap oligomers
may be reversible. On the other hand, it is troubling that the Ap oligomers did not
produce significant cognitive impairments on the days immediately following injections,
nor did repeated exposure produce enduring toxicity. These findings may suggest that it
is not just the over-production of AP oligomers which leads to neurotoxicity. Perhaps the
AD individual has some other feature which makes clearing AP oligomers more difficult.
Regardless, future research in this area is definitely warranted.
As average life expectancy continues to increase, so too does the need to find a
cure for diseases of old age, such as AD. Before cures can be developed, however,
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researchers must first determine what causes the neurodegenerative symptoms of AD.
The present study adds additional evidence to the growing body of research suggesting
that Ap oligomers disrupt memory and may play an important role in the development of
AD. Although these oligomers do appear to play a role in the development of AD, it is
important to understand that they probably are not the only the only causative factor of
the disease. Regardless, it seems that the RAM is a good animal model to use in future
studies examining the disruptive effects of Ap oligomers in rats.
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